Disorders noticed during development of pancreatic cancer: potential opportunities for early and effective diagnostics and therapy

Barbara Joanna Bałan; Ewa Zygmanowska; Dorota Magdalena Radomska-Leśniewska

doi:10.5114/ceji.2017.68698

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors

Editorial System

Submit your Manuscript

4/2017
vol. 42

Send email

Copy url:

abstract:

Review paper

Disorders noticed during development of pancreatic cancer: potential opportunities for early and effective diagnostics and therapy

Barbara Joanna Bałan

,

Ewa Zygmanowska

,

Dorota Magdalena Radomska-Leśniewska

(Centr Eur J Immunol 2017; 42 (4): 377-382)

DOI: https://doi.org/10.5114/ceji.2017.68698

Online publish date: 2017/12/30

View full text Get citation

PlumX metrics:

Pancreatic cancer, with a total five-year survival rate below 5%, represents a disease with a high level of malignancy. Some of the pancreatic cancer bad prognosis factors are nutrition disorders. Malnutrition, neither recognized nor properly referred to by the healthcare system, leads to well-documented negative health consequences in hospitalized patients including their impaired immunity, delayed post-surgery wound healing, a high risk of infectious complications, morbidity and mortality. There are numerous factors contributing to the development of pancreatic cancer, including telomerases, inflammation, angiogenesis, epigenetics and genetics factors, miRNA, pancreatic cancer stem cells. On the basis of molecular analyses, it has been established that precursor injuries may trigger pancreatic cancer when added to genetic alterations. Perhaps, combination of few presently used methods, like signal transduction modulated by K-ras, STAT3 activation, HMGB1 releasing, presence of oxidative stress and free radicals secretion, genes for proangiogenic growth factors activation or tissue-specific miRNA genes expression – will solve the problem of inadequate diagnostics.

keywords:

Disorders noticed during development of pancreatic cancer: potential opportunities for early and effective diagnostics and therapy

Barbara Joanna Bałan , Ewa Zygmanowska , Dorota Magdalena Radomska-Leśniewska

pancreatic cancer, malnutrition, tumour angiogenesis, oxidative stress, miRNA, inflammation, high-mobility group box 1 (HMBG1)

Barbara Joanna Bałan

,

Ewa Zygmanowska

,

Dorota Magdalena Radomska-Leśniewska